BAY1436032 / Bayer  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
BAY1436032 / Bayer
NCT03127735: BAY1436032 in Patients With Mutant IDH1(mIDH1) Advanced Acute Myeloid Leukemia (AML)

Completed
2
27
US, Europe
BAY1436032
Bayer
Leukemia, Myeloid, Acute
12/18
03/19

Download Options